contend that denial of medically developed treatment protocols for Gender Dysphoria patients would indeed qualify as 'malpractice'. This is not a bipartisan, science based effort.
contend that denial of medically developed treatment protocols for Gender Dysphoria patients would indeed qualify as 'malpractice'. This is not a bipartisan, science based effort.